Re: Thoughts on ZCC
in response to
by
posted on
Sep 03, 2021 05:43PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
....what would seem to be heavily discounted financing is at the top of my list.
All depends what you compare them to. You're comparing to other companies. I'm comparing to a particular OTC stock. So the PPs look pretty decent to me.